Turn Biotechnologies has filed a notice of an exempt offering of securities to raise $43,867,224.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Turn Biotechnologies is raising $43,867,224.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Anja Krammer played a key role…